LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFRCristina Scalici Gesolfo,Sebastiano Billone,Alessio Guarneri,Marco Vella,Alessandro Perez, Graziella Cangemi,Antonio Russo,Alchiede Simonato,Vincenzo SerrettaANTICANCER RESEARCH（2017）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
